Instructions for Authors

Before submission

Article types

Clinical trials and observational studies are research designs. Conference proceedings require format-specific arrangements with the editorial office; historical labels in the archive are not automatic submission categories. The APC page lists four existing fee categories; confirm the rate for an unlisted format before submission.

Manuscript structure

Adapt the structure to the article type. Completed studies report results; reviews describe evidence selection and synthesis; protocols describe the rationale, planned methods and analysis without presenting planned outcomes as completed findings.

Title page

Give the manuscript title, author names and affiliations, and the corresponding author's contact details.

Abstract

Summarize the question, methods and main findings for completed work; for a protocol, state the rationale and planned design without implying completed results.

Introduction

State the scientific context, question and antioxidant or redox rationale.

Methods

Describe the study design, relevant materials or participants, measurements or models, controls or validation, and analysis in enough detail for evaluation and repetition.

Results

For completed work, report findings and analyses without extending beyond the observations. Protocols specify planned outcomes and analysis instead of completed results.

Discussion

Interpret the findings in relation to the study design and evidence, and state relevant limitations.

End matter

Include data availability, ethics information where applicable, competing interests, funding and references.

Figures, tables and supplementary material

Assays and reproducibility

• Name the assay, endpoint and detection method.
• Report concentrations, incubation times, calibration procedure, reference compounds and units.
• Describe the material, sample extraction and preparation conditions.
• Identify positive and negative controls, independent replicates and reproducibility measures.
• Explain how activity was quantified and include relevant validation data.
• Where solvent polarity, pH or another condition is a study variable, report the series rather than a selected best-performing condition alone.

Data, code and reporting

Computational research

Describe the model, assumptions, input data, preprocessing and software or code. Report validation appropriate to the intended use, uncertainty and limits of applicability. Distinguish predictions from experimentally established effects; predictions alone do not demonstrate biological activity or clinical benefit.

Clinical, population and synthesis research

Describe participants, interventions or exposures, outcomes and analysis, addressing bias, confounding and measurement error as applicable. Reviews explain literature selection, appraisal and synthesis. Protocols state a clear rationale, complete planned methodology and analysis; completed validation or results are not implied.

• Describe data preprocessing and quality checks.
• Share analysis code or provide a sufficiently detailed workflow description.
• Use CONSORT for randomized trials, STROBE for observational studies and PRISMA for systematic reviews, where applicable.
• Apply relevant domain-specific reporting guidance to antioxidant methods and results.

Ethics and declarations

• State the appropriate ethics approval for research involving human participants or animals. Interventional clinical trials must be registered in an accepted public trial registry at or before the first participant provides consent for enrollment. The registry name, registration number, and registration date must be reported in the manuscript.
• Disclose financial and non-financial competing interests.
• Identify funding sources.
• Include a cover letter that explains the manuscript's scope fit.
• Disclose AI-assisted language support. Authors remain responsible for accuracy; AI tools cannot be listed as authors.

Submission routes

Primary route

ManuscriptZone

Alternative route

Simple manuscript submission form

Assisted route

Editorial email: [email protected]

Authors must use only one submission route for the same manuscript.

From submission to publication

Submission

Upload the manuscript, figures, tables, supplementary files and declarations through ManuscriptZone.

Initial assessment

The journal checks completeness, scope alignment and the required ethical and reporting information.

Peer review

Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts. For double-blind review, remove author names, affiliations, acknowledgments, funding details, institution names, and other identifying information from the reviewer manuscript. Provide identifying information separately in the title-page file or submission form.

Decision and revision

The editor considers the reports and communicates the decision. When revision is invited, respond to the comments point by point and identify the corresponding manuscript changes.

Proofs and publication

Accepted manuscripts proceed through copyediting and proof review. Authors check figures, tables and metadata before publication. Published articles are assigned a DOI and made open access under CC BY 4.0.

Final checklist

• The subject and evidence level fit the JAA scope.
• The manuscript and every referenced figure, table and supplementary file are ready.
• Design-appropriate methods, controls or validation, analysis and limitations are documented; laboratory assay details are included where relevant.
• Data availability, ethics, competing interests and funding statements are included.
• The cover letter explains the manuscript's scope fit.